Inherited heart diseases pose unique challenges due to their genetic origins, often affecting multiple family members across generations. Conditions such as Marfan syndrome, long QT syndrome, and dilated cardiomyopathy are caused by mutations in specific genes, leading to structural or electrical abnormalities in the heart. As these diseases may remain asymptomatic for years, genetic testing plays a crucial role in early diagnosis, allowing for proactive management to prevent complications like heart failure or arrhythmias. Treatment approaches are highly individualized, ranging from medication and lifestyle modifications to advanced interventions such as implantable devices. Research into gene therapy and other cutting-edge treatments continues to offer hope for those with genetic and inherited heart diseases, promising improved quality of life and better long-term outcomes.
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Precision nutrition for heart health: A personalized approach to cardiovascular disease prevention and management
Teji Dhami, BOOST your Health and Wellness, United States